Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., appointed Philip R. Kym, Ph.D., as its Head of Drug Discovery.  In this newly created role, Kym will oversee the direction, scientific execution, and operational management of Calico’s drug discovery programs, from target identification and validation through lead optimization and candidate selection. Kym most recently s...